BAJAJ BROKING

Notification
No new Notification messages
Vishal Mega Mart IPO is Open!
Apply for the Vishal Mega Mart IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
genomic valley biotech limited stock

GENOMIC VALLEY BIOTECH LIMITED Share Price

98.75 -1.15 (-1.15%)
Dec 12 2024 03:14 PM Miscellaneous NSE: GVBL

GENOMIC VALLEY BIOTECH LIMITED Share Price Update

As of the latest trading session, GENOMIC VALLEY BIOTECH LIMITED share price is currently at 98.75, which is down by -1.15 from its previous closing. Today, the stock has fluctuated between 95.60 and 99.80. Over the past year, GENOMIC VALLEY BIOTECH LIMITED has achieved a return of 332.09 %. In the last month alone, the return has been -1.04 %. Read More...

GENOMIC VALLEY BIOTECH LIMITED Performance

Day Range

Low95.60 High99.80
95.65

52 Week Range

Low 22.61 High 108.15
95.65

GENOMIC VALLEY BIOTECH LIMITED Share Price

539206

GVBL

img img img img
No Data Available

Open Price

99.80

Prev. Close

99.90

Volume (Shares)

8369.00

Total traded value

8.15

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

GENOMIC VALLEY BIOTECH LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 29.20
PE Ratio (TTM) 115.24
Book Value / Share 12.49
Beta 0.39
ROE 0.57%
EPS (TTM) 0.83
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.15

GENOMIC VALLEY BIOTECH LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 0.21
Operating Expense 0.06
Net Profit 0.15
Net Profit Margin (%) 71.42
Earnings Per Share (EPS) 0.48
EBITDA 0.15
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 0.16
Operating Expense 0.03
Net Profit 0.13
Net Profit Margin (%) 81.25
Earnings Per Share (EPS) 0.42
EBITDA 0.13
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.04
Net Profit -0.04
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.15
EBITDA -0.04
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 0.04
Operating Expense 0.02
Net Profit 0.02
Net Profit Margin (%) 50.00
Earnings Per Share (EPS) 0.07
EBITDA 0.02
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 0.07
Operating Expense 0.04
Net Profit 0.02
Net Profit Margin (%) 28.57
Earnings Per Share (EPS) 0.08
EBITDA 0.02
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.17
Operating Expense 0.15
Net Profit 0.02
Net Profit Margin (%) 11.76
Earnings Per Share (EPS) 0.05
EBITDA 0.02
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 2.72
Operating Expense 1.85
Net Profit 0.65
Net Profit Margin (%) 23.89
Earnings Per Share (EPS) 2.12
EBITDA 0.66
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.07
Operating Expense 0.57
Net Profit -0.01
Net Profit Margin (%) -14.28
Earnings Per Share (EPS) -0.03
EBITDA 0.12
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.21
Operating Expense 0.72
Net Profit -0.56
Net Profit Margin (%) -266.66
Earnings Per Share (EPS) -1.83
EBITDA -0.13
Effective Tax Rate (%) -12.00
Particulars MAR 2020 (Values in Cr)
Revenue 0.85
Operating Expense 0.65
Net Profit 0.29
Net Profit Margin (%) 34.11
Earnings Per Share (EPS) 0.94
EBITDA 0.57
Effective Tax Rate (%) -38.09
Particulars MAR 2024 (Values in Cr)
Book Value / Share 11.60
ROE % 0.57
ROCE % 0.57
Total Debt to Total Equity 0.00
EBITDA Margin 11.76
Particulars MAR 2023 (Values in Cr)
Book Value / Share 11.55
ROE % 28.48
ROCE % 25.67
Total Debt to Total Equity 0.00
EBITDA Margin 33.82
Particulars MAR 2022 (Values in Cr)
Book Value / Share 9.42
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.21
EBITDA Margin -428.57
Particulars MAR 2021 (Values in Cr)
Book Value / Share 14.69
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.32
EBITDA Margin -61.90
Particulars MAR 2020 (Values in Cr)
Book Value / Share 16.52
ROE % 5.84
ROCE % 5.39
Total Debt to Total Equity 0.30
EBITDA Margin 65.88
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 4.33
Total Liabilities 4.33
Total Equity 3.54
Share Outstanding 3054500
Price to Book Ratio 2.99
Return on Assets (%) 0.35
Return on Capital (%) 0.43
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 4.42
Total Liabilities 4.42
Total Equity 3.52
Share Outstanding 3054500
Price to Book Ratio 0.00
Return on Assets (%) 14.66
Return on Capital (%) 18.38
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 3.79
Total Liabilities 3.79
Total Equity 2.87
Share Outstanding 3054500
Price to Book Ratio 0.00
Return on Assets (%) -0.24
Return on Capital (%) -0.32
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 7.61
Total Liabilities 7.61
Total Equity 4.48
Share Outstanding 3054500
Price to Book Ratio 0.00
Return on Assets (%) -7.33
Return on Capital (%) -9.26
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 8.00
Total Liabilities 8.00
Total Equity 5.04
Share Outstanding 3054500
Price to Book Ratio 0.00
Return on Assets (%) 3.57
Return on Capital (%) 4.38
Particulars MAR 2024 (Values in Cr)
Net Income 0.01
Cash from Operations -0.02
Cash from Investing -0.01
Cash from Financing 0.00
Net change in Cash -0.03
Free Cash Flow -0.02
Particulars MAR 2023 (Values in Cr)
Net Income 0.91
Cash from Operations -0.77
Cash from Investing 1.52
Cash from Financing -0.70
Net change in Cash 0.03
Free Cash Flow -0.77
Particulars MAR 2022 (Values in Cr)
Net Income -0.42
Cash from Operations -2.12
Cash from Investing 3.66
Cash from Financing -1.54
Net change in Cash 0.00
Free Cash Flow -2.12
Particulars MAR 2021 (Values in Cr)
Net Income -0.50
Cash from Operations 1.48
Cash from Investing -1.57
Cash from Financing 0.06
Net change in Cash -0.02
Free Cash Flow 3.06
Particulars MAR 2020 (Values in Cr)
Net Income 0.20
Cash from Operations 0.43
Cash from Investing -0.47
Cash from Financing 0.00
Net change in Cash -0.03
Free Cash Flow 0.91
Company Name Price P/E P/B Market Cap 52 Week Low/High
Atlas Cycles (Haryana) Ltd 29.00 0.00 -0.59 18.86 0.00 / 0.00
Jaykay Enterprises Limited 128.45 141.15 4.68 1501.78 56.75 / 166.19
KESORAM INDUSTRIES LTD 230.35 0.00 -225.40 7157.15 158.50 / 234.55
MODI RUBBER LTD 127.00 14.55 0.57 318.01 80.46 / 156.75
THOMAS COOK (INDIA) LTD 217.90 36.75 6.68 10260.77 134.65 / 264.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
Atlas Cycles (Haryana) Ltd 29.00 1.57 -0.80 18.86 0.00 / 0.00
FGP LTD. 9.98 22.18 3.19 11.87 5.51 / 14.18
Jaykay Enterprises Limited 128.45 78.80 5.03 1501.78 56.75 / 166.19
KESORAM INDUSTRIES LTD 230.35 0.00 31.20 7157.15 158.50 / 234.55

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 100.00
  • 26 Days 100.80
  • 10 Days 100.70
  • 50 Days 96.60
  • 12 Days 100.40
  • 100 Days 84.50
  • 20 Days 100.60
  • 200 Days 40.10
98.23
PIVOT
First Resistance 101.67
Second Resistance 103.43
Third Resistance 106.87
First Support 96.47
Second Support 93.03
Third Support 91.27
RSI 51.75
MACD -0.40
Commodity Channel Index (CCI) -69.14
ADX 25.85
Williams % R -57.69

Over 1 Month

down

-1.04

Over 3 Months

down

37.79

Over 6 Months

down

162.89

Over 1 Year

down

332.09

Over 3 Years

down

64.35

Over 5 Years

down

64.67

GENOMIC VALLEY BIOTECH LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

GENOMIC VALLEY BIOTECH LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
45.32
Promoter Holdings
54.67
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Yogesh Agrawal Shareholding of Promoter and Promoter Group 1548500.0 50.7
Deepti Aggarwal Public Shareholding 336000.0 11.0
Amar Aggarwal Public Shareholding 276510.0 9.05
Parul Agrawal Shareholding of Promoter and Promoter Group 119400.0 3.91
Harish Chandra Sharma Public Shareholding 87654.0 2.87
Ojaswini Avantika Shareholding of Promoter and Promoter Group 2000.0 0.07

GENOMIC VALLEY BIOTECH LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About GENOMIC VALLEY BIOTECH LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by GENOMIC VALLEY BIOTECH LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Genomic Valley Biotech Ltd?

Answer Field

The share price of Genomic Valley Biotech Ltd for NSE is ₹ 0.00 and for BSE is ₹ 95.65.

What is the Market Cap of Genomic Valley Biotech Ltd?

Answer Field

The market cap of Genomic Valley Biotech Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 29.20 Cr. as of now.

What is the 52 Week High and Low of Genomic Valley Biotech Ltd?

Answer Field

The 52 Week High and Low of Genomic Valley Biotech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 108.15 and ₹ 22.61.

How to Buy Genomic Valley Biotech Ltd share?

Answer Field

You can trade in Genomic Valley Biotech Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Genomic Valley Biotech Ltd?

Answer Field

The 1 year returns on the stock has been 332.09%.

What is the Current Share Price of Genomic Valley Biotech Ltd?

Answer Field

Genomic Valley Biotech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 95.65 as on Dec 12 2024 03:14 PM.

What is the Market Cap of Genomic Valley Biotech Ltd Share?

Answer Field

The market cap of Genomic Valley Biotech Ltd for NSE ₹ 0.0 & for BSE ₹ 29.20 as on Dec 12 2024 03:14 PM.

What is the P/E Ratio of Genomic Valley Biotech Ltd Share?

Answer Field

As on Dec 12 2024 03:14 PM the price-to-earnings (PE) ratio for Genomic Valley Biotech Ltd share is 115.24.

What is the PB ratio of Genomic Valley Biotech Ltd Share?

Answer Field

As on Dec 12 2024 03:14 PM, the price-to-book (PB) ratio for Genomic Valley Biotech Ltd share is 12.49.

How to Buy Genomic Valley Biotech Ltd Share?

Answer Field

You can trade in Genomic Valley Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Genomic Valley Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Genomic Valley Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Genomic Valley Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader